{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:45:19Z","timestamp":1792226719204,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Muscle-invasive bladder cancer (MIBC) is a prevalent and aggressive malignancy. Ferroptosis and cuproptosis are recently discovered forms of programmed cell death (PCD) that have attracted much attention. However, their interactions and impacts on MIBC overall survival (OS) and treatment outcomes remain unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data from the TCGA-BLCA project (as the training set), cBioPortal database, and GEO datasets (GSE13507 and GSE32894, as the test sets) were utilized to identify hub ferroptosis\/cuproptosis-related genes (FRGs and CRGs) and develop a prognostic signature. Differential expression analysis (DEA) was conducted, followed by univariate and multivariate Cox\u2019s regression analyses and multiple machine learning (ML) techniques to select genetic features. The performance of the ferroptosis\/cuproptosis-related signature was evaluated using Kaplan\u2013Meier (K\u2013M) survival analysis and receiver-operating characteristics (ROC) curves. Mutational and tumour immune microenvironment landscapes were also explored. Real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) experiments confirmed the expression patterns of the hub genes, and functional assays assessed the effects of SCD knockdown on cell viability, proliferation, and migration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>DEA revealed dysregulated FRGs and CRGs in the TCGA MIBC cohort. SCD, DDR2, and MT1A were identified as hub genes. A prognostic signature based on the sum of the weighted expression of these genes demonstrated strong predictive efficacy in the training and test sets. Nomogram incorporating this signature accurately predicted 1-, 3-, and 5-year survival probabilities in the TCGA cohort and GSE13507 dataset. Copy number variation (CNV) and tumour immune microenvironment analysis revealed that high risk score level groups were associated with immunosuppression and lower tumour purity. The associations of risk scores with immunotherapy and chemical drugs were also explored, indicating their potential for guiding treatment for MIBC patients. The dysregulated expression patterns of three hub genes were validated by RT-qPCR experiments.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Targeting hub FRGs and CRGs could be a promising therapeutic approach for MIBC. Our prognostic model offers a new framework for MIBC subtyping and can inform personalized therapeutic strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12741-5","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T04:02:31Z","timestamp":1722916951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development of prognostic model incorporating a ferroptosis\/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Sida","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"issue":"3","key":"12741_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"12741_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"12741_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404\u201323.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"12741_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.urolonc.2018.11.015","volume":"40","author":"JB da Costa","year":"2022","unstructured":"da Costa JB, Gibb EA, Nykopp TK, Mannas M, Wyatt AW, Black PC. Molecular tumor heterogeneity in muscle invasive bladder cancer: biomarkers, subtypes, and implications for therapy. Urol Oncol. 2022;40(7):287\u201394.","journal-title":"Urol Oncol"},{"issue":"2","key":"12741_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.hoc.2014.11.003","volume":"29","author":"DJ McConkey","year":"2015","unstructured":"McConkey DJ, Choi W, Ochoa A, Siefker-Radtke A, Czerniak B, Dinney CPN. Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer. Hematol Oncol Clin North Am. 2015;29(2):377\u201394.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"12741_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187(2):235\u201356.","journal-title":"Cell"},{"issue":"11","key":"12741_CR7","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.21037\/tcr-22-1653","volume":"11","author":"H Wang","year":"2022","unstructured":"Wang H, Dai Y, Wu X, Hu B, Wang Z, Yan M. Multiomics analysis of ferroptosis-related molecular subtypes in muscle-invasive bladder cancer immunotherapy. Transl Cancer Res. 2022;11(11):4089\u2013104.","journal-title":"Transl Cancer Res"},{"key":"12741_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.997573","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Yu S, Duan H, Xia W, Wang C, Shen H. Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis. Front Genet. 2022;13: 997573.","journal-title":"Front Genet"},{"issue":"4","key":"12741_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"12741_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280\u201396.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6586","key":"12741_CR11","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361.","journal-title":"Science"},{"issue":"1","key":"12741_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer. 2023;22(1):46.","journal-title":"Mol Cancer"},{"key":"12741_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116115","volume":"171","author":"N Liu","year":"2024","unstructured":"Liu N, Chen M. Crosstalk between ferroptosis and cuproptosis: from mechanism to potential clinical application. Biomed Pharmacother. 2024;171: 116115.","journal-title":"Biomed Pharmacother"},{"key":"12741_CR14","doi-asserted-by":"publisher","first-page":"1000993","DOI":"10.3389\/fonc.2022.1000993","volume":"12","author":"C Zhao","year":"2022","unstructured":"Zhao C, Zhang Z, Jing T. A novel signature of combing cuproptosis- with ferroptosis-related genes for prediction of prognosis, immunologic therapy responses and drug sensitivity in hepatocellular carcinoma. Front Oncol. 2022;12:1000993.","journal-title":"Front Oncol"},{"key":"12741_CR15","doi-asserted-by":"publisher","first-page":"1192434","DOI":"10.3389\/fphar.2023.1192434","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Zhang W, Ma X, Wei Y, Zhou F, Li J, et al. Cuproptosis\/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer. Front Pharmacol. 2023;14:1192434.","journal-title":"Front Pharmacol"},{"issue":"1","key":"12741_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.euf.2021.01.003","volume":"8","author":"A Rizzo","year":"2022","unstructured":"Rizzo A, Mollica V, Massari F. Expression of programmed cell death ligand 1 as a predictive biomarker in metastatic urothelial carcinoma patients treated with first-line immune checkpoint inhibitors versus chemotherapy: a systematic review and meta-analysis. Eur Urol Focus. 2022;8(1):152\u20139.","journal-title":"Eur Urol Focus"},{"issue":"11","key":"12741_CR17","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","volume":"376","author":"J Bellmunt","year":"2017","unstructured":"Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, et al. Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med. 2017;376(11):1015\u201326.","journal-title":"N Engl J Med"},{"issue":"5","key":"12741_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167120","volume":"1870","author":"S Chakraborty","year":"2024","unstructured":"Chakraborty S, Sharma G, Karmakar S, Banerjee S. Multi-OMICS approaches in cancer biology: new era in cancer therapy. Biochim Biophys Acta Mol Basis Dis. 2024;1870(5): 167120.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"12741_CR19","doi-asserted-by":"crossref","unstructured":"Gao J, Mazor T, Ciftci E, Raman P, Lukasse P, Bahceci I et al. The cBioPortal for Cancer Genomics: an intuitive open-source platform for exploration, analysis and visualization of cancer genomics data. Cancer Res. 2018;78(13_Supplement):923.","DOI":"10.1158\/1538-7445.AM2018-923"},{"issue":"1","key":"12741_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-4598-9-3","volume":"9","author":"WJ Kim","year":"2010","unstructured":"Kim WJ, Kim EJ, Kim SK, Kim YJ, Ha YS, Jeong P, et al. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol Cancer. 2010;9(1):3.","journal-title":"Mol Cancer"},{"issue":"12","key":"12741_CR21","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","volume":"18","author":"G Sj\u00f6dahl","year":"2012","unstructured":"Sj\u00f6dahl G, Lauss M, L\u00f6vgren K, Chebil G, Gudjonsson S, Veerla S, et al. A molecular taxonomy for urothelial carcinoma. Clin Cancer Res. 2012;18(12):3377\u201386.","journal-title":"Clin Cancer Res"},{"key":"12741_CR22","unstructured":"Frank E Harrell J. Package \u2018Hmisc\u2019. vol. 2024. Vienna: CRAN; 2023. Available from: https:\/\/cran.r-project.org\/web\/packages\/Hmisc\/Hmisc.pdf."},{"key":"12741_CR23","unstructured":"R Core Team. R: a language and environment for statistical computing; 2024. Available from: https:\/\/www.R-project.org\/. Accessed 25 Mar 2024."},{"issue":"6","key":"12741_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565\u201374.","journal-title":"Med Decis Making"},{"issue":"D1","key":"12741_CR25","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"12741_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021800","volume":"6","author":"F Supek","year":"2011","unstructured":"Supek F, Bo\u0161njak M, \u0160kunca N, \u0160muc T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE. 2011;6(7): e21800.","journal-title":"PLoS ONE"},{"key":"12741_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis\u200c","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis\u200c. 2nd ed. Cham: Springer; 2016.","edition":"2"},{"issue":"1","key":"12741_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"12741_CR29","doi-asserted-by":"crossref","unstructured":"Kerseviciute I, Gordevicius J. aPEAR: an R package for autonomous visualization of pathway enrichment networks. Bioinformatics. 2023;39(11):btad672.","DOI":"10.1093\/bioinformatics\/btad672"},{"key":"12741_CR30","unstructured":"ThomasLinPedersen. Package \u2018ggforce\u2019. Vienna: CRAN; 2024. Available from: https:\/\/cran.r-project.org\/web\/packages\/ggforce\/ggforce.pdf. Accessed 15 Mar 2024."},{"key":"12741_CR31","doi-asserted-by":"crossref","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141.","DOI":"10.1016\/j.xinn.2021.100141"},{"issue":"1","key":"12741_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform. 2013;14(1):7.","journal-title":"BMC Bioinform"},{"issue":"1","key":"12741_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","volume":"17","author":"Y \u015eenbabao\u011flu","year":"2016","unstructured":"\u015eenbabao\u011flu Y, Gejman RS, Winer AG, Liu M, Van Allen EM, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17(1):231.","journal-title":"Genome Biol"},{"key":"12741_CR34","doi-asserted-by":"crossref","unstructured":"Wang S, He Z, Wang X, Li H, Liu XS. Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction. eLife. 2019;8:e49020.","DOI":"10.7554\/eLife.49020"},{"issue":"7","key":"12741_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158995","volume":"11","author":"S Marczok","year":"2016","unstructured":"Marczok S, Bortz B, Wang C, Pospisil H. Comprehensive analysis of genome rearrangements in eight human malignant tumor tissues. PLoS ONE. 2016;11(7): e0158995.","journal-title":"PLoS ONE"},{"issue":"9","key":"12741_CR36","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1101\/gr.092759.109","volume":"19","author":"M Krzywinski","year":"2009","unstructured":"Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19(9):1639\u201345.","journal-title":"Genome Res"},{"key":"12741_CR37","doi-asserted-by":"crossref","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41.","DOI":"10.1186\/gb-2011-12-4-r41"},{"key":"12741_CR38","doi-asserted-by":"crossref","unstructured":"Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP. GenePattern 2.0. Nat Genet. 2006;38(5):500\u20131.","DOI":"10.1038\/ng0506-500"},{"key":"12741_CR39","doi-asserted-by":"crossref","unstructured":"Quinlan AR. BEDTools: the Swiss\u2010army tool for genome feature analysis. Curr Protoc Bioinformatics. 2014;47:11.2.1\u201334.","DOI":"10.1002\/0471250953.bi1112s47"},{"issue":"1","key":"12741_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. 2020;18(1):59.","journal-title":"Cell Commun Signal"},{"key":"12741_CR41","unstructured":"Aragaki K, Yoshihara K, Vegesna R, Kim H, Verhaak R. tidyestimate: a tidy implementation of \u2018ESTIMATE\u2019; 2023. Available from: https:\/\/github.com\/KaiAragaki\/tidyestimate. Accessed 3 Mar 2024."},{"issue":"5","key":"12741_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"key":"12741_CR43","unstructured":"Kassambara A. Package \u2018rstatix\u2019. Vienna: CRAN; 2023. Available from: https:\/\/cran.r-project.org\/web\/packages\/rstatix\/rstatix.pdf. Accessed Mar 15, 2024."},{"issue":"1","key":"12741_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu J, Li K, Zhang W, Wan C, Zhang J, Jiang P, et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 2020;12(1):21.","journal-title":"Genome Med"},{"issue":"51","key":"12741_CR45","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.21105\/joss.02306","volume":"5","author":"D Makowski","year":"2020","unstructured":"Makowski D, Ben-Shachar MS, Patil I, L\u00fcdecke D. Methods and algorithms for correlation analysis in R. J Open Source Softw. 2020;5(51):2306.","journal-title":"J Open Source Softw"},{"issue":"6","key":"12741_CR46","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1093\/bib\/bbz142","volume":"21","author":"Q Dong","year":"2020","unstructured":"Dong Q, Li F, Xu Y, Xiao J, Xu Y, Shang D, et al. RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data. Brief Bioinform. 2020;21(6):2167\u201374.","journal-title":"Brief Bioinform"},{"key":"12741_CR47","unstructured":"Bove DS, Li L, Dedic J, Kelkhoff D, Kunzmann K, Lang BM et al. mmrm: mixed models for repeated measures. vol. 2024. Vienna: CRAN; 2024. Available from: https:\/\/CRAN.R-project.org\/package=mmrm."},{"key":"12741_CR48","unstructured":"Lenth RV. Package \u2018emmeans\u2019; 2024. Available from: https:\/\/CRAN.R-project.org\/package=emmeans. Accessed 25 Mar 2024."},{"issue":"9","key":"12741_CR49","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.ejca.2010.02.047","volume":"46","author":"HJ Mackay","year":"2010","unstructured":"Mackay HJ, Hirte H, Colgan T, Covens A, MacAlpine K, Grenci P, et al. Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours. Eur J Cancer. 2010;46(9):1573\u20139.","journal-title":"Eur J Cancer"},{"issue":"3","key":"12741_CR50","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/cancers16030512","volume":"16","author":"J Wang","year":"2024","unstructured":"Wang J, Li J, Liu J, Chan KY, Lee HS, Lin KN, et al. Interplay of ferroptosis and cuproptosis in cancer: dissecting metal-driven mechanisms for therapeutic potentials. Cancers (Basel). 2024;16(3):512.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"12741_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","volume":"32","author":"D Tang","year":"2022","unstructured":"Tang D, Chen X, Kroemer G. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res. 2022;32(5):417\u20138.","journal-title":"Cell Res"},{"issue":"1","key":"12741_CR52","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41392-022-01014-x","volume":"7","author":"S-R Li","year":"2022","unstructured":"Li S-R, Bu L-L, Cai L. Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway. Sig Transduct Target Ther. 2022;7(1):158.","journal-title":"Sig Transduct Target Ther"},{"issue":"6","key":"12741_CR53","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.trecan.2023.03.003","volume":"9","author":"U Sen","year":"2023","unstructured":"Sen U, Coleman C, Sen T. Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis. Trends Cancer. 2023;9(6):480\u20139.","journal-title":"Trends Cancer"},{"issue":"9","key":"12741_CR54","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1158\/0008-5472.CAN-21-4044","volume":"82","author":"CS Kubota","year":"2022","unstructured":"Kubota CS, Espenshade PJ. Targeting Stearoyl-CoA desaturase in solid tumors. Cancer Res. 2022;82(9):1682\u20138.","journal-title":"Cancer Res"},{"key":"12741_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.730716","volume":"11","author":"J Sun","year":"2021","unstructured":"Sun J, Yue W, You J, Wei X, Huang Y, Ling Z, et al. Identification of a novel ferroptosis-related gene prognostic signature in bladder cancer. Front Oncol. 2021;11: 730716.","journal-title":"Front Oncol"},{"issue":"1","key":"12741_CR56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40537-022-00641-z","volume":"9","author":"CP Gui","year":"2022","unstructured":"Gui CP, Li JY, Fu LM, Luo CG, Zhang C, Tang YM, et al. Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer. J Big Data. 2022;9(1):88.","journal-title":"J Big Data"},{"issue":"4","key":"12741_CR57","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000519645","volume":"45","author":"X Xu","year":"2022","unstructured":"Xu X, Yu T, Wang Z. Discoidin domain receptor 2: a new target in cancer. Oncol Res Treat. 2022;45(4):205\u201315.","journal-title":"Oncol Res Treat"},{"issue":"3","key":"12741_CR58","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/cas.14789","volume":"112","author":"Y Gao","year":"2021","unstructured":"Gao Y, Zhou J, Li J. Discoidin domain receptors orchestrate cancer progression: a focus on cancer therapies. Cancer Sci. 2021;112(3):962\u20139.","journal-title":"Cancer Sci"},{"issue":"1","key":"12741_CR59","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-018-0645-x","volume":"11","author":"M Si","year":"2018","unstructured":"Si M, Lang J. The roles of metallothioneins in carcinogenesis. J Hematol Oncol. 2018;11(1):107.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"12741_CR60","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41418-022-01087-9","volume":"30","author":"K Wang","year":"2023","unstructured":"Wang K, Wang S, Zhang Y, Xie L, Song X, Song X. SNORD88C guided 2\u2032-O-methylation of 28S rRNA regulates SCD1 translation to inhibit autophagy and promote growth and metastasis in non-small cell lung cancer. Cell Death Differ. 2023;30(2):341\u201355.","journal-title":"Cell Death Differ"},{"issue":"22","key":"12741_CR61","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1158\/0008-5472.CAN-12-1329","volume":"72","author":"X Du","year":"2012","unstructured":"Du X, Wang Q-R, Chan E, Merchant M, Liu J, French D, et al. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth. Cancer Res. 2012;72(22):5843\u201355.","journal-title":"Cancer Res"},{"issue":"1","key":"12741_CR62","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1186\/s12864-019-6412-8","volume":"20","author":"Y Li","year":"2019","unstructured":"Li Y, Umbach DM, Bingham A, Li Q-J, Zhuang Y, Li L. Putative biomarkers for predicting tumor sample purity based on gene expression data. BMC Genomics. 2019;20(1):1021.","journal-title":"BMC Genomics"},{"issue":"20","key":"12741_CR63","doi-asserted-by":"publisher","first-page":"6279","DOI":"10.1158\/1078-0432.CCR-16-2598","volume":"23","author":"C Zhang","year":"2017","unstructured":"Zhang C, Cheng W, Ren X, Wang Z, Liu X, Li G, et al. Tumor purity as an underlying key factor in glioma. Clin Cancer Res. 2017;23(20):6279\u201391.","journal-title":"Clin Cancer Res"},{"key":"12741_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.782529","volume":"9","author":"S Lou","year":"2021","unstructured":"Lou S, Zhang J, Yin X, Zhang Y, Fang T, Wang Y, et al. Comprehensive characterization of tumor purity and its clinical implications in gastric cancer. Front Cell Dev Biol. 2021;9: 782529.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"12741_CR65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12885-023-10532-y","volume":"23","author":"Y Ding","year":"2023","unstructured":"Ding Y, Chu L, Cao Q, Lei H, Li X, Zhuang Q. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC. BMC Cancer. 2023;23(1):45.","journal-title":"BMC Cancer"},{"issue":"1","key":"12741_CR66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12894-024-01404-z","volume":"24","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhao Q, Huang H, Lin X. Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma. BMC Urol. 2024;24(1):26.","journal-title":"BMC Urol"},{"issue":"22","key":"12741_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202212267","volume":"35","author":"B Guo","year":"2023","unstructured":"Guo B, Yang F, Zhang L, Zhao Q, Wang W, Yin L, et al. Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy. Adv Mater. 2023;35(22): e2212267.","journal-title":"Adv Mater"},{"issue":"20","key":"12741_CR68","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","volume":"79","author":"L Tesfay","year":"2019","unstructured":"Tesfay L, Paul BT, Konstorum A, Deng Z, Cox AO, Lee J, et al. Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death. Cancer Res. 2019;79(20):5355\u201366.","journal-title":"Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12741-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T16:04:35Z","timestamp":1722960275000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12741-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12741"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12741-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"958"}}